Anthera Pharmaceuticals Inc. (ANTH) OTC MARKETS

$0 0 (0.00%)

Market Cap: $5236

As of 04/08/22 04:00 PM EDT. Market closed.

(ANTH)

Anthera Pharmaceuticals Inc. (ANTH) OTC MARKETS

$0 0 (0.00%)

Market Cap: $5236

As of 04/08/22 04:00 PM EDT. Market closed.

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
J. Craig Thompson
Full Time Employees
21
URL
Address
25801 Industrial Blvd Ste B, California, Hayward, 94545-2223.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
J. Craig Thompson
Full Time Employees
21
Address
25801 Industrial Blvd Ste B, California, Hayward, 94545-2223.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$0 - $0.09
Volume
0
Avg. Volume (30 days)
0
Market Cap
$5236
Dividend Yield
0.00%
P/E
-
Shares Outstanding
26,179,302
Open
$0
Previous Close
$0
Days Range
$0 - $0
52 week range
$0 - $0.09
Volume
0
Avg. Volume (30 days)
0
Market Cap
$5236
Dividend Yield
0.00%
P/E
-
Shares Outstanding
26,179,302

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ANTHERA PHARMACEUTICALS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
THOMPSON JOHN CRAIG President & CEO Sep 20, 2017 Buy $1.32 8,550 11,286 19,848 Sep 20, 2017, 07:14 PM
TRUEX PAUL F Director Sep 07, 2017 Buy $1.34 5,000 6,700 16,793 Sep 07, 2017, 06:56 PM
THOMPSON JOHN CRAIG President & CEO Sep 07, 2017 Buy $1.43 10,400 14,893 11,298 Sep 07, 2017, 06:56 PM
THOMPSON JOHN CRAIG President & CEO Sep 07, 2017 Option Exercise $1.43 10,400 14,893 17,590 Sep 07, 2017, 02:43 PM
TRUEX PAUL F Chief Executive Officer Sep 20, 2016 Option Exercise $2.08 5,008 10,417 5,008 Sep 22, 2016, 07:29 PM
Mueller Brian Director Dec 23, 2015 Option Exercise $2.89 10,000 28,900 10,000 Dec 24, 2015, 12:35 PM
Hislop Colin Chief Medical Officer Nov 13, 2015 Option Exercise $1.61 12,500 20,125 31,647 Nov 18, 2015, 06:53 PM
Hislop Colin Chief Medical Officer Nov 13, 2015 Sale $5.31 12,500 66,341 19,147 Nov 18, 2015, 06:53 PM
ODINK DEBRA Chief Technology Officer Oct 12, 2015 Sale $6.15 1,205 7,411 7,896 Oct 13, 2015, 08:02 PM
TRUEX PAUL F President and CEO Jun 30, 2014 Option Exercise $3.39 699 2,370 14,709 Jul 01, 2014, 08:09 PM
TRUEX PAUL F President and CEO Jun 30, 2014 Option Exercise $2.08 2,000 4,160 13,845 Jul 01, 2014, 08:09 PM
TRUEX PAUL F President and CEO Jun 30, 2013 Option Exercise $3.30 6,250 20,625 80,190 Mar 28, 2014, 09:23 PM
TRUEX PAUL F President and CEO Mar 25, 2014 Option Exercise $3.30 8,974 29,614 11,845 Mar 28, 2014, 09:23 PM
LIU MAY Chief Accounting Officer Mar 25, 2014 Option Exercise $3.30 529 1,746 3,677 Mar 27, 2014, 09:57 PM
ODINK DEBRA Chief Technology Officer Mar 25, 2014 Option Exercise $3.30 2,783 9,184 6,601 Mar 27, 2014, 09:57 PM
TRUEX PAUL F President and CEO Mar 25, 2014 Option Exercise $3.30 6,250 20,625 597,787 Mar 27, 2014, 09:56 PM
TRUEX PAUL F President and CEO Mar 25, 2014 Option Exercise $3.30 7,622 25,153 9,333 Mar 27, 2014, 09:56 PM
ODINK DEBRA Chief Technology Officer Jun 30, 2013 Option Exercise $0.49 2,248 1,102 75,074 Jul 02, 2013, 09:17 PM
LIU MAY Chief Accounting Officer Jun 30, 2013 Option Exercise $0.49 675 331 33,655 Jul 02, 2013, 09:17 PM
Thompson David E. Director Jun 24, 2013 Buy $0.53 100,000 53,000 128,201 Jun 26, 2013, 05:24 PM
DZIURZYNSKI BOGDAN Director May 31, 2013 Buy $0.59 10,000 5,900 10,000 Jun 04, 2013, 07:26 PM
ORBIMED ADVISORS LLC Director Jan 30, 2013 Buy $0.66 5,700,000 3,762,000 7,462,000 Feb 01, 2013, 08:19 PM
ORBIMED ADVISORS LLC Director Jan 25, 2013 Buy $0.65 1,762,000 1,142,481 1,762,000 Jan 29, 2013, 04:54 PM
TRUEX PAUL F President and CEO Jan 03, 2013 Option Exercise $0.69 17,454 12,043 66,412 Jan 08, 2013, 05:29 PM
KILFOIL GEORGINA SVP,Product Dev.& Project Mgmt Jan 03, 2013 Option Exercise $0.69 2,410 1,663 30,035 Jan 07, 2013, 09:20 PM
ODINK DEBRA Chief Technology Officer Jan 03, 2013 Option Exercise $0.69 3,409 2,352 31,812 Jan 07, 2013, 09:18 PM
Hislop Colin Chief Medical Officer Jan 03, 2013 Option Exercise $0.69 4,560 3,146 84,959 Jan 07, 2013, 09:17 PM
LOWE CHRISTOPHER P. C.F.O. and C.B.O. Jan 03, 2013 Option Exercise $0.69 8,660 5,975 41,336 Jan 07, 2013, 09:17 PM
KILFOIL GEORGINA SVP,Product Dev.& Project Mgmt Jun 30, 2012 Option Exercise $0.69 2,068 1,427 24,601 Jul 03, 2012, 07:27 PM
ODINK DEBRA Chief Technology Officer Jun 30, 2012 Option Exercise $0.69 1,838 1,268 24,821 Jul 03, 2012, 07:27 PM
ORBIMED ADVISORS LLC Director Jun 29, 2012 Sale $0.73 1,283,300 942,071 0 Jul 03, 2012, 03:19 PM
HENNEY CHRISTOPHER S Director Jun 29, 2012 Buy $0.75 100,000 74,930 100,000 Jul 02, 2012, 05:46 PM
HENNEY CHRISTOPHER S Director Jun 29, 2012 Buy $0.75 100,000 74,930 202,429 Jul 02, 2012, 05:46 PM
TRUEX PAUL F President and CEO Jun 29, 2012 Buy $0.76 20,000 15,200 645,125 Jul 02, 2012, 03:53 PM
ORBIMED ADVISORS LLC Director Mar 22, 2012 Sale $2.40 1,306,700 3,140,131 1,283,300 Mar 22, 2012, 06:15 PM
ORBIMED ADVISORS LLC Director Mar 21, 2012 Sale $2.87 125,000 358,312 2,590,000 Mar 22, 2012, 06:15 PM
ORBIMED ADVISORS LLC Director Mar 20, 2012 Sale $2.90 116,800 338,638 2,715,000 Mar 22, 2012, 06:15 PM
ODINK DEBRA Chief Technology Officer Mar 01, 2012 Sale $6.57 2,000 13,140 26,659 Mar 05, 2012, 04:01 PM
Hislop Colin Chief Medical Officer Feb 23, 2012 Option Exercise $0.26 40,000 10,400 79,519 Feb 27, 2012, 05:26 PM
TRUEX PAUL F President and C.E.O. Feb 15, 2012 Sale $7.84 15,000 117,600 625,125 Feb 17, 2012, 05:15 PM
Hislop Colin Chief Medical Officer Feb 03, 2012 Sale $8.20 30,000 246,000 27,967 Feb 06, 2012, 08:04 PM
LOWE CHRISTOPHER P. C.F.O. and C.B.O. Feb 01, 2012 Sale $7.66 15,000 114,900 31,151 Feb 03, 2012, 04:01 PM
ODINK DEBRA Chief Technology Officer Feb 01, 2012 Sale $7.67 2,000 15,340 21,241 Feb 03, 2012, 04:01 PM
TRUEX PAUL F President and C.E.O. Jan 31, 2012 Option Exercise $0.26 20,000 5,200 640,125 Feb 02, 2012, 07:37 PM
HEALY JAMES Director Jan 28, 2012 Option Exercise $4.19 12,000 50,280 32,443 Jan 31, 2012, 05:53 PM
TRUEX PAUL F President and Chief Executive Jan 17, 2012 Sale $6.75 15,000 101,250 627,125 Jan 19, 2012, 05:03 PM
ODINK DEBRA Chief Technology Officer Jan 10, 2012 Sale $6.51 800 5,205 23,241 Jan 12, 2012, 12:58 PM
ODINK DEBRA Chief Technology Officer Jan 06, 2012 Sale $6.50 1,200 7,800 24,441 Jan 10, 2012, 02:27 PM
HEALY JAMES Director Dec 30, 2011 Sale $6.22 25,000 155,625 3,298,684 Jan 03, 2012, 08:31 PM
SOFINNOVA VENTURE PARTNERS VI L P 10% Owner Dec 30, 2011 Sale $6.22 25,000 155,625 3,298,684 Jan 03, 2012, 08:31 PM
HEALY JAMES Director Dec 22, 2011 Sale $6.22 25,000 155,605 3,319,314 Dec 23, 2011, 06:22 PM
HEALY JAMES Director Dec 21, 2011 Sale $6.51 25,000 162,770 3,339,944 Dec 23, 2011, 06:22 PM
SOFINNOVA VENTURE PARTNERS VI L P 10% Owner Dec 21, 2011 Sale $6.51 25,000 162,770 3,339,944 Dec 23, 2011, 06:22 PM
SOFINNOVA VENTURE PARTNERS VI L P 10% Owner Dec 22, 2011 Sale $6.22 25,000 155,605 3,319,314 Dec 23, 2011, 06:22 PM
SOFINNOVA VENTURE PARTNERS VI L P 10% Owner Mar 04, 2010 Option Exercise $6.75 1,253,635 8,462,757 3,360,574 Dec 22, 2011, 06:24 PM
SOFINNOVA VENTURE PARTNERS VI L P 10% Owner Mar 04, 2010 Option Exercise $5.53 741,215 4,097,698 2,326,015 Dec 22, 2011, 06:24 PM
TRUEX PAUL F President and CEO Dec 15, 2011 Sale $6.34 15,000 95,065 642,125 Dec 16, 2011, 09:53 PM
ORBIMED ADVISORS LLC Director Dec 13, 2011 Sale $6.50 16,200 105,300 2,831,800 Dec 13, 2011, 06:37 PM
ORBIMED ADVISORS LLC Director Dec 09, 2011 Sale $6.75 40,000 270,000 2,848,000 Dec 13, 2011, 06:37 PM
ORBIMED ADVISORS LLC Director Nov 18, 2011 Sale $6.50 3,000 19,500 2,888,000 Nov 18, 2011, 05:57 PM
ORBIMED ADVISORS LLC Director Nov 17, 2011 Sale $6.67 24,000 160,080 2,891,000 Nov 18, 2011, 05:57 PM
ORBIMED ADVISORS LLC Director Nov 16, 2011 Sale $6.87 25,000 171,750 2,915,000 Nov 18, 2011, 05:57 PM
TRUEX PAUL F President and CEO Nov 15, 2011 Sale $6.96 30,000 208,704 672,125 Nov 17, 2011, 04:01 PM
ORBIMED ADVISORS LLC Director Nov 15, 2011 Sale $6.93 50,000 346,500 2,940,000 Nov 15, 2011, 06:29 PM
ORBIMED ADVISORS LLC Director Nov 14, 2011 Sale $6.95 5,000 34,750 2,990,000 Nov 15, 2011, 06:29 PM
ORBIMED ADVISORS LLC Director Nov 11, 2011 Sale $7.14 5,000 35,700 2,995,000 Nov 15, 2011, 06:29 PM
Hislop Colin Chief Medical Officer Nov 08, 2011 Option Exercise $0.26 15,000 3,900 72,967 Nov 10, 2011, 05:06 PM
Hislop Colin Chief Medical Officer Nov 08, 2011 Sale $6.74 15,000 101,163 57,967 Nov 10, 2011, 05:06 PM
LOWE CHRISTOPHER P. Chief Financial Officer & CBO Nov 03, 2011 Sale $6.88 15,000 103,236 46,151 Nov 04, 2011, 08:24 PM
LOWE CHRISTOPHER P. Chief Financial Officer & CBO Oct 25, 2011 Sale $7.07 4,637 32,784 0 Oct 27, 2011, 07:48 PM
TRUEX PAUL F President and CEO Oct 21, 2011 Sale $6.25 23,235 145,219 649,004 Oct 25, 2011, 09:55 PM
TRUEX PAUL F President and CEO Oct 18, 2011 Sale $6.25 6,745 42,156 660,360 Oct 20, 2011, 09:28 PM
LOWE CHRISTOPHER P. Chief Financial Officer & CBO Aug 08, 2011 Option Exercise $1.34 10,000 13,400 61,151 Aug 09, 2011, 06:21 PM
TRUEX PAUL F President and CEO Aug 08, 2011 Option Exercise $0.26 50,000 13,000 90,512 Aug 09, 2011, 06:16 PM
LOWE CHRISTOPHER P. Chief Financial Officer & CBO Aug 03, 2011 Sale $6.88 14,600 100,432 51,151 Aug 04, 2011, 08:08 PM
LOWE CHRISTOPHER P. Chief Financial Officer & CBO Aug 02, 2011 Sale $7.31 5,000 36,571 4,937 Aug 04, 2011, 08:08 PM
TRUEX PAUL F President and CEO Jul 15, 2011 Sale $7.95 15,000 119,258 667,125 Jul 18, 2011, 05:40 PM
Hislop Colin Chief Medical Officer Jul 12, 2011 Option Exercise $0.26 15,000 3,900 57,967 Jul 14, 2011, 04:15 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner Jul 07, 2011 Option Exercise $2.42 19,563 47,264 5,357,528 Jul 11, 2011, 05:49 PM
TRUEX PAUL F President and CEO Jun 30, 2011 Option Exercise $8.17 48,500 396,245 40,512 Jul 05, 2011, 06:37 PM
LOWE CHRISTOPHER P. Chief Financial Officer & CBO Jun 30, 2011 Option Exercise $8.17 23,500 191,995 65,751 Jul 05, 2011, 06:34 PM
KILFOIL GEORGINA SVP, Prod. Dev. & Project Mngm Jun 30, 2011 Option Exercise $8.17 5,625 45,956 16,875 Jul 05, 2011, 06:31 PM
Hislop Colin Chief Medical Officer Jun 30, 2011 Option Exercise $8.17 17,500 142,975 42,967 Jul 05, 2011, 06:28 PM
ODINK DEBRA VP, Pharmaceutical R&D Jun 30, 2011 Option Exercise $8.17 3,670 29,984 25,641 Jul 05, 2011, 06:23 PM
Hislop Colin Chief Medical Officer Jun 29, 2011 Option Exercise $0.26 10,000 2,600 60,062 Jun 30, 2011, 08:06 PM
LOWE CHRISTOPHER P. Chief Financial Officer & CBO Jun 21, 2011 Option Exercise $1.31 20,000 26,200 87,645 Jun 22, 2011, 08:11 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner Jun 16, 2011 Sale $8.67 3,100 26,877 4,836,202 Jun 20, 2011, 05:46 PM
TRUEX PAUL F President and CEO Jun 15, 2011 Sale $8.30 15,000 124,539 682,125 Jun 17, 2011, 07:50 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner Jun 14, 2011 Sale $8.81 699 6,158 4,839,011 Jun 15, 2011, 08:21 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner Jun 13, 2011 Sale $8.80 1,300 11,440 4,839,645 Jun 15, 2011, 08:21 PM
ORBIMED ADVISORS LLC Director Jun 10, 2011 Sale $8.18 30,000 245,400 3,000,000 Jun 10, 2011, 06:28 PM
ORBIMED ADVISORS LLC Director Jun 09, 2011 Sale $8.11 37,000 300,070 3,030,000 Jun 10, 2011, 06:28 PM
ORBIMED ADVISORS LLC Director Jun 08, 2011 Sale $8.02 33,000 264,660 3,067,000 Jun 10, 2011, 06:28 PM
ORBIMED ADVISORS LLC Director May 18, 2011 Sale $8.03 69,334 556,752 3,139,000 Jun 06, 2011, 06:19 AM
ORBIMED ADVISORS LLC Director May 17, 2011 Sale $8.32 100,000 832,000 3,208,334 Jun 06, 2011, 06:19 AM
ORBIMED ADVISORS LLC Director May 16, 2011 Sale $7.20 12,000 86,400 3,308,334 Jun 06, 2011, 06:19 AM
ORBIMED ADVISORS LLC Director May 11, 2011 Sale $7.22 13,000 93,860 3,320,334 Jun 06, 2011, 06:16 AM
ORBIMED ADVISORS LLC Director May 10, 2011 Sale $7.23 106,400 769,272 3,333,334 Jun 06, 2011, 06:16 AM
ORBIMED ADVISORS LLC Director May 09, 2011 Sale $7.26 10,000 72,600 3,439,734 Jun 06, 2011, 06:16 AM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner May 26, 2011 Sale $8.60 4,800 41,280 4,840,823 May 31, 2011, 07:31 PM
ORBIMED ADVISORS LLC Director May 25, 2011 Sale $8.65 4,800 41,520 3,134,200 May 27, 2011, 06:58 PM
ORBIMED ADVISORS LLC Director May 26, 2011 Sale $8.53 34,200 291,726 3,100,000 May 27, 2011, 06:58 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner May 25, 2011 Sale $8.67 32,750 283,943 4,845,172 May 25, 2011, 06:42 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner May 24, 2011 Sale $8.42 52,196 439,490 4,874,844 May 25, 2011, 06:42 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner May 23, 2011 Sale $8.18 26,703 218,431 4,922,134 May 25, 2011, 06:42 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner May 17, 2011 Sale $8.29 13,900 115,231 5,059,578 May 19, 2011, 06:23 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner May 19, 2011 Sale $8.03 125,000 1,003,750 4,946,327 May 19, 2011, 06:23 PM
TRUEX PAUL F President and CEO May 16, 2011 Sale $7.16 15,000 107,339 692,003 May 18, 2011, 07:28 PM
ORBIMED ADVISORS LLC Director May 18, 2011 Sale $8.03 69,334 556,752 3,139,000 May 18, 2011, 07:12 PM
ORBIMED ADVISORS LLC Director May 17, 2011 Sale $8.32 100,000 832,000 3,208,334 May 18, 2011, 07:12 PM
ORBIMED ADVISORS LLC Director May 16, 2011 Sale $7.20 12,000 86,400 3,308,334 May 18, 2011, 07:12 PM
ORBIMED ADVISORS LLC Director May 10, 2011 Sale $7.23 106,400 769,272 3,333,334 May 11, 2011, 08:21 PM
ORBIMED ADVISORS LLC Director May 09, 2011 Sale $7.26 10,000 72,600 3,439,734 May 11, 2011, 08:21 PM
ORBIMED ADVISORS LLC Director May 11, 2011 Sale $7.22 13,000 93,860 3,320,334 May 11, 2011, 08:21 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner May 05, 2011 Sale $7.01 387,700 2,717,777 5,072,171 May 05, 2011, 05:36 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner May 04, 2011 Sale $7.00 200,000 1,400,000 5,423,428 May 05, 2011, 05:36 PM
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner May 03, 2011 Sale $7.00 100,000 700,000 5,604,628 May 05, 2011, 05:36 PM
ODINK DEBRA VP, Pharmaceutical R&D Apr 13, 2011 Option Exercise $1.51 3,311 5,000 29,311 Apr 14, 2011, 08:36 PM
TRUEX PAUL F President and CEO Apr 13, 2011 Option Exercise $0.26 30,000 7,800 121,122 Apr 14, 2011, 08:35 PM
Thompson David E. Director Jan 03, 2011 Option Exercise $1.39 11,558 16,067 11,558 Jan 05, 2011, 08:50 PM
ORBIMED ADVISORS LLC 10% Owner Sep 30, 2010 Buy $4.08 19,900 81,192 3,449,734 Oct 04, 2010, 08:08 PM
ODINK DEBRA VP, Pharmaceutical R&D Sep 24, 2010 Buy $4.20 1,000 4,200 26,000 Sep 24, 2010, 09:22 PM
LOWE CHRISTOPHER P. CFO & VP of Administration Sep 24, 2010 Buy $4.18 5,000 20,900 62,523 Sep 24, 2010, 09:20 PM
Leheny A. Rachel Director Sep 24, 2010 Buy $3.00 250,000 750,000 1,423,896 Sep 24, 2010, 09:19 PM
Trias Joaquim Sr. VP, Preclinical Developmen Sep 21, 2010 Option Exercise $1.51 4,380 6,614 198,546 Sep 23, 2010, 08:44 PM
Hislop Colin Sr. VP, Cardiovasc. Prod. Sep 21, 2010 Option Exercise $0.26 14,683 3,818 15,183 Sep 23, 2010, 08:40 PM
Hislop Colin Sr. VP, Cardiovasc. Prod. Aug 18, 2010 Buy $4.80 500 2,400 500 Aug 20, 2010, 02:37 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
THOMPSON JOHN CRAIG President & CEO 09/20/2017 11,286
TRUEX PAUL F Director 09/07/2017 6,700
THOMPSON JOHN CRAIG President & CEO 09/07/2017 14,893
THOMPSON JOHN CRAIG President & CEO 09/07/2017 14,893
TRUEX PAUL F Chief Executive Officer 09/20/2016 10,417
Mueller Brian Director 12/23/2015 28,900
Hislop Colin Chief Medical Officer 11/13/2015 20,125
Hislop Colin Chief Medical Officer 11/13/2015 66,341
ODINK DEBRA Chief Technology Officer 10/12/2015 7,411
TRUEX PAUL F President and CEO 06/30/2014 2,370
TRUEX PAUL F President and CEO 06/30/2014 4,160
TRUEX PAUL F President and CEO 06/30/2013 20,625
TRUEX PAUL F President and CEO 03/25/2014 29,614
LIU MAY Chief Accounting Officer 03/25/2014 1,746
ODINK DEBRA Chief Technology Officer 03/25/2014 9,184
TRUEX PAUL F President and CEO 03/25/2014 20,625
TRUEX PAUL F President and CEO 03/25/2014 25,153
ODINK DEBRA Chief Technology Officer 06/30/2013 1,102
LIU MAY Chief Accounting Officer 06/30/2013 331
Thompson David E. Director 06/24/2013 53,000
DZIURZYNSKI BOGDAN Director 05/31/2013 5,900
ORBIMED ADVISORS LLC Director 01/30/2013 3,762,000
ORBIMED ADVISORS LLC Director 01/25/2013 1,142,481
TRUEX PAUL F President and CEO 01/03/2013 12,043
KILFOIL GEORGINA SVP,Product Dev.& Project Mgmt 01/03/2013 1,663
ODINK DEBRA Chief Technology Officer 01/03/2013 2,352
Hislop Colin Chief Medical Officer 01/03/2013 3,146
LOWE CHRISTOPHER P. C.F.O. and C.B.O. 01/03/2013 5,975
KILFOIL GEORGINA SVP,Product Dev.& Project Mgmt 06/30/2012 1,427
ODINK DEBRA Chief Technology Officer 06/30/2012 1,268
ORBIMED ADVISORS LLC Director 06/29/2012 942,071
HENNEY CHRISTOPHER S Director 06/29/2012 74,930
HENNEY CHRISTOPHER S Director 06/29/2012 74,930
TRUEX PAUL F President and CEO 06/29/2012 15,200
ORBIMED ADVISORS LLC Director 03/22/2012 3,140,131
ORBIMED ADVISORS LLC Director 03/21/2012 358,312
ORBIMED ADVISORS LLC Director 03/20/2012 338,638
ODINK DEBRA Chief Technology Officer 03/01/2012 13,140
Hislop Colin Chief Medical Officer 02/23/2012 10,400
TRUEX PAUL F President and C.E.O. 02/15/2012 117,600
Hislop Colin Chief Medical Officer 02/03/2012 246,000
LOWE CHRISTOPHER P. C.F.O. and C.B.O. 02/01/2012 114,900
ODINK DEBRA Chief Technology Officer 02/01/2012 15,340
TRUEX PAUL F President and C.E.O. 01/31/2012 5,200
HEALY JAMES Director 01/28/2012 50,280
TRUEX PAUL F President and Chief Executive 01/17/2012 101,250
ODINK DEBRA Chief Technology Officer 01/10/2012 5,205
ODINK DEBRA Chief Technology Officer 01/06/2012 7,800
HEALY JAMES Director 12/30/2011 155,625
SOFINNOVA VENTURE PARTNERS VI L P 10% Owner 12/30/2011 155,625
HEALY JAMES Director 12/22/2011 155,605
HEALY JAMES Director 12/21/2011 162,770
SOFINNOVA VENTURE PARTNERS VI L P 10% Owner 12/21/2011 162,770
SOFINNOVA VENTURE PARTNERS VI L P 10% Owner 12/22/2011 155,605
SOFINNOVA VENTURE PARTNERS VI L P 10% Owner 03/04/2010 8,462,757
SOFINNOVA VENTURE PARTNERS VI L P 10% Owner 03/04/2010 4,097,698
TRUEX PAUL F President and CEO 12/15/2011 95,065
ORBIMED ADVISORS LLC Director 12/13/2011 105,300
ORBIMED ADVISORS LLC Director 12/09/2011 270,000
ORBIMED ADVISORS LLC Director 11/18/2011 19,500
ORBIMED ADVISORS LLC Director 11/17/2011 160,080
ORBIMED ADVISORS LLC Director 11/16/2011 171,750
TRUEX PAUL F President and CEO 11/15/2011 208,704
ORBIMED ADVISORS LLC Director 11/15/2011 346,500
ORBIMED ADVISORS LLC Director 11/14/2011 34,750
ORBIMED ADVISORS LLC Director 11/11/2011 35,700
Hislop Colin Chief Medical Officer 11/08/2011 3,900
Hislop Colin Chief Medical Officer 11/08/2011 101,163
LOWE CHRISTOPHER P. Chief Financial Officer & CBO 11/03/2011 103,236
LOWE CHRISTOPHER P. Chief Financial Officer & CBO 10/25/2011 32,784
TRUEX PAUL F President and CEO 10/21/2011 145,219
TRUEX PAUL F President and CEO 10/18/2011 42,156
LOWE CHRISTOPHER P. Chief Financial Officer & CBO 08/08/2011 13,400
TRUEX PAUL F President and CEO 08/08/2011 13,000
LOWE CHRISTOPHER P. Chief Financial Officer & CBO 08/03/2011 100,432
LOWE CHRISTOPHER P. Chief Financial Officer & CBO 08/02/2011 36,571
TRUEX PAUL F President and CEO 07/15/2011 119,258
Hislop Colin Chief Medical Officer 07/12/2011 3,900
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner 07/07/2011 47,264
TRUEX PAUL F President and CEO 06/30/2011 396,245
LOWE CHRISTOPHER P. Chief Financial Officer & CBO 06/30/2011 191,995
KILFOIL GEORGINA SVP, Prod. Dev. & Project Mngm 06/30/2011 45,956
Hislop Colin Chief Medical Officer 06/30/2011 142,975
ODINK DEBRA VP, Pharmaceutical R&D 06/30/2011 29,984
Hislop Colin Chief Medical Officer 06/29/2011 2,600
LOWE CHRISTOPHER P. Chief Financial Officer & CBO 06/21/2011 26,200
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner 06/16/2011 26,877
TRUEX PAUL F President and CEO 06/15/2011 124,539
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner 06/14/2011 6,158
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner 06/13/2011 11,440
ORBIMED ADVISORS LLC Director 06/10/2011 245,400
ORBIMED ADVISORS LLC Director 06/09/2011 300,070
ORBIMED ADVISORS LLC Director 06/08/2011 264,660
ORBIMED ADVISORS LLC Director 05/18/2011 556,752
ORBIMED ADVISORS LLC Director 05/17/2011 832,000
ORBIMED ADVISORS LLC Director 05/16/2011 86,400
ORBIMED ADVISORS LLC Director 05/11/2011 93,860
ORBIMED ADVISORS LLC Director 05/10/2011 769,272
ORBIMED ADVISORS LLC Director 05/09/2011 72,600
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner 05/26/2011 41,280
ORBIMED ADVISORS LLC Director 05/25/2011 41,520
ORBIMED ADVISORS LLC Director 05/26/2011 291,726
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner 05/25/2011 283,943
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner 05/24/2011 439,490
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner 05/23/2011 218,431
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner 05/17/2011 115,231
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner 05/19/2011 1,003,750
TRUEX PAUL F President and CEO 05/16/2011 107,339
ORBIMED ADVISORS LLC Director 05/18/2011 556,752
ORBIMED ADVISORS LLC Director 05/17/2011 832,000
ORBIMED ADVISORS LLC Director 05/16/2011 86,400
ORBIMED ADVISORS LLC Director 05/10/2011 769,272
ORBIMED ADVISORS LLC Director 05/09/2011 72,600
ORBIMED ADVISORS LLC Director 05/11/2011 93,860
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner 05/05/2011 2,717,777
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner 05/04/2011 1,400,000
VANTAGEPOINT VENTURE ASSOCIATES IV LLC 10% Owner 05/03/2011 700,000
ODINK DEBRA VP, Pharmaceutical R&D 04/13/2011 5,000
TRUEX PAUL F President and CEO 04/13/2011 7,800
Thompson David E. Director 01/03/2011 16,067
ORBIMED ADVISORS LLC 10% Owner 09/30/2010 81,192
ODINK DEBRA VP, Pharmaceutical R&D 09/24/2010 4,200
LOWE CHRISTOPHER P. CFO & VP of Administration 09/24/2010 20,900
Leheny A. Rachel Director 09/24/2010 750,000
Trias Joaquim Sr. VP, Preclinical Developmen 09/21/2010 6,614
Hislop Colin Sr. VP, Cardiovasc. Prod. 09/21/2010 3,818
Hislop Colin Sr. VP, Cardiovasc. Prod. 08/18/2010 2,400
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2018
12/31/2016
-46.34%
5Q
03/31/2018
09/30/2016
-45.83%
6Q
03/31/2018
06/30/2016
-45.32%
7Q
03/31/2018
03/31/2016
-44.65%
8Q
03/31/2018
12/31/2015
-37.79%
9Q
Load More

Period of Report: 03/31/2018

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
12/31/2016
-46.34%
5Q
09/30/2016
-45.83%
6Q
06/30/2016
-45.32%
7Q
03/31/2016
-44.65%
8Q
12/31/2015
-37.79%
9Q
Load More